Marshall Wace, LLP Valneva Se Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Valneva Se stock. As of the latest transaction made, Marshall Wace, LLP holds 31,211 shares of VALN stock, worth $282,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,211Holding current value
$282,459% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VALN
# of Institutions
20Shares Held
5.27MCall Options Held
0Put Options Held
0-
Novo Holdings Hellerup, G72.35MShares$21.2 Million2.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA2.29MShares$20.7 Million1.18% of portfolio
-
General American Investors CO Inc354KShares$3.21 Million0.26% of portfolio
-
Wells Fargo & Company San Francisco, CA154KShares$1.39 Million0.0% of portfolio
-
Morgan Stanley New York, NY33KShares$298,5320.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $625M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...